Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab Use

Anna Kemp-Casey, Nicole Pratt, Emmae Ramsay, Elizabeth E. Roughead

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)411-417
Number of pages7
JournalApplied Health Economics and Health Policy
Issue number3
Publication statusPublished - 1 Jun 2019
Externally publishedYes

Cite this